Anti-transthyretin Antibodies


The invention provides antibodies that specifically bind to transthyretin (TTR). The antibodies can be used for treating or effecting prophylaxis of diseases or disorders associated with TTR accumulation or accumulation of TTR deposits (e.g., TTR amyloidosis). The antibodies can also be used for diagnosing TTR amyloidosis and inhibiting or reducing aggregation of TTR, among other applications.

Download PDF
Document Preview
Document History
  • Publication: Jan 30, 2018
  • Application: Jul 2, 2016
    US US 201615201416 A
  • Priority: Jul 2, 2016
    US US 201615201416 A
  • Priority: Jan 28, 2016
    US US 201615009666 A
  • Priority: Dec 11, 2015
    US US 201562266557 P
  • Priority: Jan 28, 2015
    US US 201562109001 P

Download Citation

Sign in to the Lens